Olin Corporation (OLN)
Net profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 452,000 | 599,800 | 810,500 | 1,087,900 | 1,326,900 | 1,436,900 | 1,512,400 | 1,446,100 | 1,296,700 | 957,100 | -170,400 | -646,300 | -969,900 | -1,014,100 | -233,100 | -133,000 | -11,300 | 119,200 | 270,100 | 348,700 |
Revenue (ttm) | US$ in thousands | 6,694,800 | 7,037,300 | 7,697,800 | 8,622,000 | 9,248,600 | 9,480,800 | 9,472,500 | 9,030,900 | 8,436,700 | 7,905,800 | 6,991,400 | 6,022,700 | 5,550,200 | 5,283,200 | 5,432,700 | 5,796,000 | 5,940,900 | 6,188,800 | 8,361,600 | 10,222,500 |
Net profit margin | 6.75% | 8.52% | 10.53% | 12.62% | 14.35% | 15.16% | 15.97% | 16.01% | 15.37% | 12.11% | -2.44% | -10.73% | -17.48% | -19.19% | -4.29% | -2.29% | -0.19% | 1.93% | 3.23% | 3.41% |
December 31, 2023 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $452,000K ÷ $6,694,800K
= 6.75%
The net profit margin of Olin Corp. has shown a decreasing trend over the past eight quarters. Starting at 15.30% in Q1 2022, the margin gradually declined to 6.73% in Q4 2023. This indicates that the company's profitability relative to its revenues has been diminishing. The drop in net profit margin could be attributed to various factors such as increasing costs, pricing pressures, or changes in revenue mix. It is essential for Olin Corp. to closely monitor its expenses and operational efficiency to improve its net profit margin and ensure sustainable profitability in the long term.
Peer comparison
Dec 31, 2023
Company name
Symbol
Net profit margin
Olin Corporation
OLN
6.75%
Balchem Corporation
BCPC
11.77%
Chemours Co
CC
-4.03%
FMC Corporation
FMC
29.53%
Ingevity Corp
NGVT
-0.34%
Innospec Inc
IOSP
7.13%